HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Li Selected Research

GW 3965

11/2022The liver X receptors agonist GW3965 attenuates depressive-like behaviors and suppresses microglial activation and neuroinflammation in hippocampal subregions in a mouse depression model.
4/2003Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Li Research Topics

Disease

1519Neoplasms (Cancer)
12/2024 - 07/2001
370Inflammation (Inflammations)
05/2024 - 05/2002
303Infections
05/2024 - 05/2005
281Neoplasm Metastasis (Metastasis)
05/2024 - 03/2002
232Breast Neoplasms (Breast Cancer)
05/2024 - 06/2002
132Hepatocellular Carcinoma (Hepatoma)
05/2024 - 02/2003
126Fibrosis (Cirrhosis)
03/2024 - 05/2004
119Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 12/2006
119Carcinogenesis
05/2024 - 01/2007
108Lung Neoplasms (Lung Cancer)
07/2024 - 04/2010
107Hypoxia (Hypoxemia)
05/2024 - 01/2005
105COVID-19
04/2024 - 01/2020
100Pain (Aches)
04/2024 - 02/2006
97Hypertension (High Blood Pressure)
03/2024 - 08/2002
96Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 05/2002
93Cardiovascular Diseases (Cardiovascular Disease)
06/2024 - 07/2008
89Type 2 Diabetes Mellitus (MODY)
02/2024 - 11/2002
88Obesity
05/2024 - 04/2003
80Asthma (Bronchial Asthma)
05/2024 - 05/2002
80Body Weight (Weight, Body)
03/2024 - 02/2004
79Hemorrhage
04/2024 - 12/2007
79Carcinoma (Carcinomatosis)
11/2023 - 03/2002
76Stroke (Strokes)
03/2024 - 03/2004
74Myocardial Infarction
05/2024 - 02/2006
74Prostatic Neoplasms (Prostate Cancer)
03/2024 - 10/2002
73Stomach Neoplasms (Stomach Cancer)
12/2024 - 11/2002
72Insulin Resistance
05/2024 - 11/2002
67Wounds and Injuries (Trauma)
05/2024 - 07/2005
65Heart Failure
05/2024 - 08/2002
61Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 01/2003
61Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 02/2009
60Atherosclerosis
05/2024 - 01/2008
60Leukemia
05/2024 - 03/2007
53Glioma (Gliomas)
12/2024 - 09/2011
53Adenocarcinoma of Lung
03/2024 - 07/2013
52Ischemic Stroke
05/2024 - 03/2004
52Virus Diseases (Viral Diseases)
04/2024 - 03/2007
52Ischemia
04/2024 - 09/2005
52Cognitive Dysfunction
03/2024 - 01/2009
52Alzheimer Disease (Alzheimer's Disease)
09/2023 - 01/2005
50Brain Neoplasms (Brain Tumor)
05/2024 - 04/2007
50Reperfusion Injury
04/2024 - 02/2009
49Necrosis
04/2024 - 02/2004
45Colitis
05/2024 - 03/2009
45Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 01/2008
44Melanoma (Melanoma, Malignant)
02/2024 - 01/2006
43Sepsis (Septicemia)
05/2024 - 05/2010
43Disease Progression
05/2024 - 02/2008
42Adenocarcinoma
05/2024 - 06/2003
42Squamous Cell Carcinoma of Head and Neck
04/2024 - 01/2012

Drug/Important Bio-Agent (IBA)

568Proteins (Proteins, Gene)FDA Link
05/2024 - 07/2002
327Biomarkers (Surrogate Marker)IBA
05/2024 - 06/2003
190MicroRNAs (MicroRNA)IBA
12/2024 - 01/2009
187CytokinesIBA
05/2024 - 05/2004
164Messenger RNA (mRNA)IBA
05/2024 - 05/2002
140Glucose (Dextrose)FDA LinkGeneric
04/2024 - 11/2002
122LipidsIBA
05/2024 - 08/2004
113RNA (Ribonucleic Acid)IBA
07/2024 - 07/2002
106Therapeutic UsesIBA
05/2024 - 05/2008
104EnzymesIBA
04/2024 - 08/2004
97DNA (Deoxyribonucleic Acid)IBA
05/2024 - 03/2002
95Long Noncoding RNAIBA
04/2024 - 01/2015
85Interleukin-6 (Interleukin 6)IBA
04/2024 - 08/2004
77Cisplatin (Platino)FDA LinkGeneric
07/2024 - 09/2002
76Transcription Factors (Transcription Factor)IBA
03/2024 - 01/2008
74VaccinesIBA
04/2024 - 03/2008
69LigandsIBA
07/2024 - 01/2006
69Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 04/2006
66Peptides (Polypeptides)IBA
05/2024 - 08/2002
66Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 08/2004
65Small Interfering RNA (siRNA)IBA
01/2024 - 04/2006
63Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 06/2004
62Antiviral Agents (Antivirals)IBA
05/2024 - 10/2008
60AntibodiesIBA
05/2024 - 10/2003
60Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 03/2002
58Insulin (Novolin)FDA Link
05/2024 - 05/2006
57CollagenIBA
05/2024 - 11/2007
54Phosphotransferases (Kinase)IBA
05/2024 - 12/2008
53AntioxidantsIBA
05/2024 - 02/2006
52AntigensIBA
12/2023 - 05/2002
51Oxygen (Dioxygen)IBA
03/2024 - 09/2003
51Immunoglobulin G (IgG)IBA
03/2024 - 03/2005
51Indicators and Reagents (Reagents)IBA
03/2024 - 06/2004
49ErbB Receptors (EGF Receptor)IBA
01/2024 - 05/2002
47InterferonsIBA
04/2024 - 01/2008
46CateninsIBA
04/2024 - 04/2011
45CholesterolIBA
05/2024 - 03/2009
45InterleukinsIBA
02/2024 - 04/2006
44Circular RNAIBA
04/2024 - 01/2017
44Blood Glucose (Blood Sugar)IBA
02/2024 - 10/2007
43Doxorubicin (Adriamycin)FDA LinkGeneric
02/2024 - 12/2007
43Polysaccharides (Glycans)IBA
12/2023 - 08/2004

Therapy/Procedure

775Therapeutics
07/2024 - 11/2004
227Drug Therapy (Chemotherapy)
06/2024 - 09/2002
146Radiotherapy
06/2024 - 03/2006
132Immunotherapy
07/2024 - 07/2007
81Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2024 - 11/2002
64Aftercare (After-Treatment)
04/2024 - 03/2004
52Lasers (Laser)
05/2024 - 02/2005
50Percutaneous Coronary Intervention
04/2024 - 03/2013